dsip portal Predict, Optimize, Recommend, and Track for Adaptive Logistics (PORTAL)​ – Army SBIR|STTR Program Capturing Non-Dilutive Funding from Department

Advance your research confidently with our meticulously synthesised BPC-157 peptide, delivering precise, reproducible, and reliable research outcomes

Wezlana is a biosimilar to and interchangeable with J&Js Stelara and like Stelara, is approved to treat moderate to severe plaque psoriasis, active psoriatic arthritis, moderately to severely active Crohns disease and moderately to severely active ulcerative colitis

However, these non-medical treatments may not yield satisfactory outcomes for individuals with severe hair loss

For chronic prevention of gout, the essential message is that present treatments work in a huge majority of patients and are generally well-tolerated

The second objective is to investigate the potential therapeutic applications of kisspeptin-10 in reproductive disorders